Cat#:RP-0266H;Product Name:Recombinant Human CD153 / CD30L / TNFSF8 Protein;Synonym:CD153,CD30L,CD30LG;Description:A DNA sequence encoding the human CD30L (NP_001235.1) (Gln63-Asp234) was expressed with two additional amino acids (Gly & Pro ) at the N-terminus.;Source:Human Cells;Predicted N Terminal:Gln 63;Molecular Characterization:The recombinant human CD30L consists of 172 amino acids and predicts a molecular mass of 19.6 kDa.;Purity:Greater than 90 % as determined by SDS-PAGE.;Endotoxin:<1.0 EU per ug protein as determined by the LAL method.;Bioactivity:Please contact us for detailed information;Formulation:Lyophilized from sterile PBS, pH 7.4.;Stability:Recombinant Proteins are stable for up to 1 year from date of receipt at -70℃;Reconstitution:Please see related COA for specific instructions.;Storage:Avoid repeated freeze-thaw cycles. In lyophilized state for 1 year (4-8℃); Upon reconstitution under sterile conditions for 2 weeks (4-8℃) or 3 months (-20℃ to -70℃).;
Recombinant Human CD153 / CD30L / TNFSF8 Protein
Online Inquiry
Cat#:
RP-0266H
Product Name:
Recombinant Human CD153 / CD30L / TNFSF8 Protein
Synonym:
CD153,CD30L,CD30LG
Description:
A DNA sequence encoding the human CD30L (NP_001235.1) (Gln63-Asp234) was expressed with two additional amino acids (Gly & Pro ) at the N-terminus.
Source:
Human Cells
Predicted N Terminal:
Gln 63
Molecular Characterization:
The recombinant human CD30L consists of 172 amino acids and predicts a molecular mass of 19.6 kDa.
Purity:
Greater than 90 % as determined by SDS-PAGE.
Endotoxin:
<1.0 EU per ug protein as determined by the LAL method.
Bioactivity:
Please contact us for detailed information
Formulation:
Lyophilized from sterile PBS, pH 7.4.
Stability:
Recombinant Proteins are stable for up to 1 year from date of receipt at -70℃
Reconstitution:
Please see related COA for specific instructions.
Storage:
Avoid repeated freeze-thaw cycles. In lyophilized state for 1 year (4-8℃); Upon reconstitution under sterile conditions for 2 weeks (4-8℃) or 3 months (-20℃ to -70℃).